OrthoSpace

About:

OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market.

Top Investors: Triventures, Johnson & Johnson Robotics and Digital Solutions, HealthpointCapital, Smith & Nephew, Fuerst Technology Innovations

Description:

OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures. The company’s first product has the CE mark and is currently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.

Total Funding Amount:

$15M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Caesarea, Hefa, Israel

Founded Date:

2009-01-01

Contact Email:

info(AT)orthospace.co.il

Founders:

Assaf Dekel

Number of Employees:

11-50

Last Funding Date:

2016-12-01

IPO Status:

Private

Industries: